| Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment | Journal of hepatology |  | | 2023 | 316 | 344 |
|
| A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity | Science translational medicine |  | | 2022 | 276 | 0 |
|
